City Central Orthopedic Group is categorized under Orthopedic Doctors and Physicians in Chula Vista, CA .
City Central Orthopedic Group was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Joseph Garcia at the company’s single location by writing to 752 Medical Center Court, Chula Vista, California CA 91911 or by phoning (619) 397-0173. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | City Central Orthopedic Group |
| Contact Person: | Joseph Garcia |
| Address: | 752 Medical Center Court, Chula Vista, California 91911 |
| Phone Number: | (619) 397-0173 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Orthopedic Doctors and Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
City Central Orthopedic Group was started in 0 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joseph Garcia for inquiries that concern City Central Orthopedic Group by calling the company number (619) 397-0173, as your correspondence is most welcome. Additionally, the physical location of the single location of City Central Orthopedic Group can be found at the coordinates as well as the street address 752 Medical Center Court in Chula Vista, California 91911.
For its online presence, you may visit City Central Orthopedic Group’s website at and engage with its social media outlets through on Twitter and on Facebook.